VIVUS (VVUS) Qsymia Prescriptions Now Said to Be Up 25% in Week 6, In-Line with Views
Tweet Send to a Friend
VIVUS (Nasdaq: VVUS) is now higher on the session heading into its third-quarter earnings report tomorrow, as new Qsymia data ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
